Pierre Fabre Dermo-cosmetique

Pierre Fabre Medicament

Stéphane Poigny

Sylvie Daunes-Marion

Françoise Belaubre

Jean-Hilaire Saurat

Daniel Redoules

Hélène Hernandez-Pigeon

Guy Serre

Anne Mandeau

Nathalie Castex-Rizzi

Houcine Rahali

El Bachir Kaloun

Francoise Belaubre

Olivier Sorg

Rémi Rabot

Karim Bedjeguelal

Yves Brunel

Marie-Françoise Aries

Serge Grisoni

Hélène Duplan

Rachid Rahali

Michel Simon

Hugues Bienayme

Patrick Bogdanowicz

Marguerite Leveque

Nathalie Castex Rizzi

Gürkan Kaya

Philippe Uriac

Antoine Dumoulin

Bachir Kaloun El

Estelle Marchal

Pascaline Klein

Marie Françoise Aries

Marie Florence Galliano

Laetitia Lemercier

Marguerite Lévêque

Eric Tam

Marie-Claire Mechin

Marie-Florence Galliano

Daniel Bacqueville

Behrooz Kasraee

Sylvie Daunes Marion

Hugues Bienhayme

The present invention relates to a novel combination comprising an extract of watercress, an extract of Indian cress, and ATP, and to the use of said combination in the field of hair science, more particularly in the treatment or prevention of alopecia.

Combination of aqueous extracts of watercress and nasturtium and ATP for use in the treatment of alopecia

The present invention relates to the novel combination of pongamia oil and 4-t-butylcyclohexanol, and to the uses thereof in the fields of cosmetics and dermatology to combat redness. More specifically, the present invention relates to the cosmetic use of a composition comprising said combination to combat rosacea.

Cosmetic composition comprising a combination of pongamia oil and 4-t-butylcyclohexanol for the treatment of rosacea

An association comprising a peptide is described containing the sequence A-Lys-Gly-His-Lys-NH(SEQ ID NO: 1), wherein A is the radical corresponding to a Cto Csaturated or unsaturated fatty acid, and glyceryl laurate or one of the derivatives thereof. The use thereof for stimulating hair growth is also described.

Association of a tetrapeptide and a glyceryl ester for treating androgenic alopecia

The present invention relates to a combination comprising a hyaluronic acid or a salt thereof and a sulphated polysaccharide of which the molecular weight is between 5 and 25 kDa, which is of use in particular for combating the signs of skin ageing or for treating and healing skin wounds.

Combination of a hyaluronic acid and of a sulphated polysaccharide

The present invention relates to new monoterpene derivatives of chalcone or dihydrochalcone and their use as a depigmenting agent.

Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents

The present invention relates to the activation of peptidyl arginine deiminase (PADs) 1 and/or 3 in the epidermis by at least one active agent used alone or in combination, namely caffeine, acefylline and/or theobromine in a cosmetic and/or pharmaceutical composition. The present invention also relates to the use of the aforementioned active agents in cosmetics and/or therapeutics, alone or in combination, in order to improve the barrier functions of the epidermis, to prevent and/or treat symptoms related to dry skin or to improve and/or promote hydration of the keratinous layer. Finally, the invention relates to increasing the activity of PAD1 and/or PAD3 in the epidermis.

Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof

The present invention relates to a compound of general formula (I) in which: &#x2014;Rand Rare simultaneously or independently H, OH, OCHor a C-Calkyl radical, &#x2014;Rand Rare simultaneously CH, &#x2014;or Ris H and Ris CH, CHCHor an isopropyl radical or a phenyl radical, &#x2014;Ris a C-Calkyl radical or a 3-phenylpropanyl or 2,2-diphenylethanyl radical.

Acridinedione derivatives for treating pigmentation disorders and ageing of the skin

The present invention relates to L-glutamate-derived compounds of general formula (I) in which the R radical is a linear or branched Cto Calkyl group, .&#x2014;or the benzyl radical, .&#x2014;or the phenethyl radical, for topical use as a medicament (or as a dermatological active ingredient) intended for the treatment and/or prevention of inflammatory dermatoses.

Glutamate derivatives for topical use as immunomodulatory active ingredient

The invention relates to a compound of general formula (I) characterized in that:

Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof

The present invention relates to Formula (I), wherein&#x2014;if X=NH, each of R, R, R, Rrepresents a hydrogen atom; if X=N, the core is aromatic, and R, Rand Rrepresent hydrogen atoms, and R1=H, halogen, aryl, heteroaryl, alkenyl or acetylenyl; or R, R, R, Rare defined such that R1 or R2 or R3 or R4 represents a methyl group, and the three other radicals represent a hydrogen atom. 

Lipogenesis inhibitor compounds

The present invention relates to a cosmetic or pharmaceutical composition for cutaneous application, whose goal is the depigmentation of the skin.

Use of delta-tocopheryl-carbohydrate as a depigmenting agent

The invention relates to compound of generic formula (I) in which: Rand Rrepresent: OH, a hydrogen atom, a C-Calkyl radical a C-Calkoxy radical, a halogen, or OCOR; Rrepresents: a C-Calkyl radical a C-Calkenyl radical comprising at least one unsaturation; Rrepresents: COR, a glucide substituted or not by one or more acetyl radical(s); Rrepresents: a C-Calkyl radical or a C-Calkenyl radical comprising at least one unsaturation; Rand Rrepresent:&#x2014;simultaneously a hydrogen atom or a methyl radical, or&#x2014;when Rrepresents a hydrogen atom, Rrepresents a C-Calkyl radical or a phenyl substituted or not by one or more C-Calkoxy radical(s) or one or more halogen(s) or&#x2014;Rand Rare bonded together and form a C-Ccycloalkyl, and pharmaceutically or cosmetically acceptable salts. 

Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders

The present invention relates to a compound of the general formula (I) where: X&#x2550;S, SO or SO; and one of the radicals Rand Ris a hydrogen atom and the other is a radical: a Cto Clinear or branched alkyl, optionally substituted by one or more halogen atom(s); a Cto Clinear or branched alkenyl, optionally substituted by one or more halogen atom(s); an aralkyl, optionally substituted by one or more Cto Calkoxy group(s); or a CORor CONHR, but not simultaneously, where Ris a radical: a Cto Clinear or branched alkyl, optionally substituted by one or more halogen atom(s); a Cto Clinear or branched alkenyl, optionally substituted by one or more halogen atom(s); an aralkyl, optionally substituted by one or more Cto Calkoxy group(s); an aralkenyl, optionally substituted by one or more Cto Calkoxy groups and/or one or more OH group(s); or an aryl radical, optionally substituted by one or more Cto Calkoxy group(s).

Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof

The present invention relates to a compound with the following general formula (I): in which: Ris a hydrocarbon chain of an unsaturated fatty acid from Cto Cincluding at least one unsaturation; and Rand Rare, independently or simultaneously: a hydrogen or a C-Calkyl or a phenyl; and R: a hydrogen atom or COR, where Ris a hydrocarbon chain of an unsaturated fatty acid from Cto Cincluding at least one unsaturation, advantageously 1 to 6 and preferably 1 to 4.

Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof

The present invention relates to inhibitors of protein kinases of formula I: which can be used in the treatment of various diseases, notably cancer, inflammation or disorders of the central nervous system. It also relates to pharmaceutical compositions containing the compounds according to the invention and their use in therapy.

Growing community of inventors

Saubens, France

Stéphane Poigny